These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 876953)

  • 21. Plasma mexiletine concentrations following combined oral and intramuscular administration.
    Bradbrook ID; Feldschreiber P; Morrison PJ; Rogers HJ; Spector RG
    Eur J Clin Pharmacol; 1981 Mar; 19(4):301-4. PubMed ID: 7286033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High pressure liquid chromatographic assay for mexiletine in serum.
    Grech-Bélanger O; Turgeon J; Gilbert M
    J Chromatogr Sci; 1984 Nov; 22(11):490-2. PubMed ID: 6501531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of mexiletine and its metabolites in serum by liquid chromatography with fluorescence detection.
    Farid NA; White SM
    J Chromatogr; 1983 Jul; 275(2):458-62. PubMed ID: 6619254
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose independent pharmacokinetics of mexiletine in healthy volunteers.
    Pringle T; Fox J; McNeill JA; Kinney CD; Liddle J; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):319-21. PubMed ID: 3964531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mexiletine in plasma by high pressure liquid chromatography.
    Kelly R; Christmore D; Smith R; Doshier L; Jacobs SL
    Ther Drug Monit; 1981; 3(3):279-86. PubMed ID: 7324093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved liquid-chromatographic determination of mexiletine, an antiarrhythmic drug, in plasma.
    Mastropaolo W; Holmes DR; Osborn MJ; Rooke J; Moyer TP
    Clin Chem; 1984 Feb; 30(2):319-22. PubMed ID: 6692546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mexiletine in normal volunteers.
    Campbell NP; Kelly JG; Adgey AA; Shanks RG
    Br J Clin Pharmacol; 1978 Oct; 6(4):372-3. PubMed ID: 698033
    [No Abstract]   [Full Text] [Related]  

  • 28. Liquid chromatographic determination of mexiletine and tocainide in human plasma with fluorescence detection after reaction with a modified o-phthalaldehyde reagent.
    Gupta RN; Lew M
    J Chromatogr; 1985 Nov; 344():221-30. PubMed ID: 3936856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between mexiletine and digoxin.
    Day T; Hunt D
    Med J Aust; 1983 Dec 10-24; 2(12):630. PubMed ID: 6366499
    [No Abstract]   [Full Text] [Related]  

  • 30. Determination of mexiletine in biological fluids by high-performance liquid chromatography.
    Breithaupt H; Wilfling M
    J Chromatogr; 1982 Jun; 230(1):97-105. PubMed ID: 7107772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with NONMEM: analysis of serum concentration data in patients treated with mexiletine and lidocaine.
    Vozeh S; Wenk M; Follath F
    Drug Metab Rev; 1984; 15(1-2):305-15. PubMed ID: 6547664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of mexiletine plasma levels due to delayed hepatic metabolism in patients with chronic liver disease.
    Nitsch J; Steinbeck G; Lüderitz B
    Eur Heart J; 1983 Nov; 4(11):810-4. PubMed ID: 6653593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gas chromatographic determination of mexiletine in human plasma with flame ionization detection after reaction with carbon disulphide.
    Ji SG; Kong QH; Li XL; Li P
    Biomed Chromatogr; 1993; 7(4):196-9. PubMed ID: 8219696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of mexiletine in renal insufficiency.
    Baudinet G; Henrard L; Quinaux N; El Allaf D; de Landsheere C; Carlier J; Dresse A
    Acta Cardiol Suppl; 1980; (25):55-65. PubMed ID: 6966453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mexiletine determination in serum by capillary gas chromatography with nitrogen-selective detection.
    LeGatt DF; Audette RJ; Youzwishen O; Stewart T
    J Pharm Biomed Anal; 1991; 9(10-12):1147-50. PubMed ID: 1822186
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of spontaneous changes in urinary pH on mexiletine plasma concentrations and excretion during chronic administration to healthy volunteers.
    Johnston A; Burgess CD; Warrington SJ; Wadsworth J; Hamer NA
    Br J Clin Pharmacol; 1979 Oct; 8(4):349-52. PubMed ID: 41549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptation of the dose of mexiletine according to pharmacokinetic data.
    Bogaert M
    Acta Cardiol Suppl; 1980; (25):67-73. PubMed ID: 6966454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective solid-phase extraction of mexiletine from human serum prior to its GLC analysis.
    Marko V
    Pharmazie; 1987 Jun; 42(6):387-9. PubMed ID: 3671458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable pharmacokinetics of mexiletine.
    Kaye CM; Kiddie MA; Turner P
    Postgrad Med J; 1977; 53 Suppl 1():56-9. PubMed ID: 17856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.